arrow
J

Johannes Oldenburg

university clinic bonn
H指数:81
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Emicizumab long-term outcomes and coagulation biomarkers in mild or moderate hemophilia A without inhibitors (HAVEN 6)

艾美珠单抗在无抑制剂的轻度或中度血友病A患者中的长期疗效及凝血生物标志物(HAVEN 6)

2026-10-230
PRE
FRONTIER5: Safety and patient experience of a direct switch from emicizumab to denecimig (Mim8) in patients with haemophilia A with or without inhibitors

FRONTIER5:从emicizumab直接转换为denecimig(Mim8)在有无抑制剂的血友病A患者中的安全性与患者体验

2026-09-120
OAAI
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins

AI赋能的靶向癌细胞表面蛋白的迷你结合物的发现与生化优化

2026-08-200
OAAI
Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A

F8基因中的大片段缺失可预测严重血友病A患者免疫耐受诱导失败。

2025-10-100
OAAI
Sustained Survival Benefit of Emicizumab and Postponed Immunosuppression in Acquired Hemophilia A

艾美珠单抗的持续生存获益及获得性血友病A中免疫抑制治疗的推迟

2025-08-140
OAAI